{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:00:43Z","timestamp":1791946843295,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical and Health Technology Innovation Project of Chinese Academy of Medical Sciences","award":["No.2022-I2M-C&T-B-100"],"award-info":[{"award-number":["No.2022-I2M-C&T-B-100"]}]},{"name":"1-3-5 project for disciplines of Excellence Clinical Research Incubation Project","award":["No. 2021HXFH012"],"award-info":[{"award-number":["No. 2021HXFH012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A significant proportion of patients with epilepsy have an unknown etiology and lack effective targeted therapeutic drugs. Patent Foramen Ovale (PFO) induces hypoxia and microembolism, leading to cerebral neurological dysfunction and increased epilepsy risk. This study aims to assess the efficacy and safety of PFO closure for relieving epileptic seizures in patients with refractory epilepsy associated with PFO.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods\/design<\/jats:title>\n                <jats:p>Recruitment takes place at the West China Hospital of Sichuan University, China, for an open-label, randomized controlled clinical trial. The trial will include 110 patients with refractory epilepsy and PFO. Disease diagnoses will conform to the diagnostic criteria of the International League Against Epilepsy (ILAE) for refractory epilepsy and the American Society of Echocardiography (ASE) for PFO. Refractory epilepsy and high-grade right-to-left shunt (RLS) of the PFO will be further diagnosed using 24-hour video electroencephalogram and transthoracic echocardiography with contrast injection, respectively. Eligible participants require a secondary or higher volume of RLS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry (ChiCTR2200065681). Registered on November 11, 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03317-0","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T06:02:10Z","timestamp":1690437730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The efficacy and safety of patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): a prospectively randomized control trial of an innovative surgical therapy for refractory epilepsy patients with PFO of high-grade right-to-left shunt"],"prefix":"10.1186","volume":"23","author":[{"given":"Ji","family":"Shuming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Yusha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"2","key":"3317_CR1","doi-asserted-by":"publisher","first-page":"100392","DOI":"10.1016\/j.cpcardiol.2018.08.004","volume":"45","author":"MK Teshome","year":"2020","unstructured":"Teshome MK, et al. Patent Foramen Ovale: a Comprehensive Review. Curr Probl Cardiol. 2020;45(2):100392.","journal-title":"Curr Probl Cardiol"},{"key":"3317_CR2","doi-asserted-by":"publisher","first-page":"15086","DOI":"10.1038\/nrdp.2015.86","volume":"2","author":"S Homma","year":"2016","unstructured":"Homma S, et al. Patent foramen ovale. Nat Rev Dis Primers. 2016;2:15086.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"3317_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.7326\/M18-3485","volume":"170","author":"E Le Moigne","year":"2019","unstructured":"Le Moigne E, et al. Patent Foramen Ovale and ischemic stroke in patients with Pulmonary Embolism: a prospective cohort study. Ann Intern Med. 2019;170(11):756\u201363.","journal-title":"Ann Intern Med"},{"key":"3317_CR4","doi-asserted-by":"crossref","unstructured":"Cao W et al. The patent Foramen Ovale and Migraine: Associated Mechanisms and Perspectives from MRI evidence. Brain Sci, 2022. 12(7).","DOI":"10.3390\/brainsci12070941"},{"issue":"8","key":"3317_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, et al. Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol. 2019;18(8):795\u2013804.","journal-title":"Lancet Neurol"},{"issue":"3","key":"3317_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1526-4610.2006.00374.x","volume":"46","author":"P Wilmshurst","year":"2006","unstructured":"Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache. 2006;46(3):429\u201334.","journal-title":"Headache"},{"issue":"1","key":"3317_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1378\/chest.12-0334","volume":"143","author":"ZF Shaikh","year":"2013","unstructured":"Shaikh ZF, et al. Patent foramen ovale in severe obstructive sleep apnea: clinical features and effects of closure. Chest. 2013;143(1):56\u201363.","journal-title":"Chest"},{"issue":"1","key":"3317_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1559-0275-12-2","volume":"12","author":"MF Lopez","year":"2015","unstructured":"Lopez MF, et al. Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux. Clin Proteom. 2015;12(1):2.","journal-title":"Clin Proteom"},{"issue":"6","key":"3317_CR9","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1161\/01.CIR.86.6.1902","volume":"86","author":"ND Bridges","year":"1992","unstructured":"Bridges ND, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86(6):1902\u20138.","journal-title":"Circulation"},{"issue":"6","key":"3317_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1540-8183.2003.01054.x","volume":"16","author":"R Schrader","year":"2003","unstructured":"Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale. J Interv Cardiol. 2003;16(6):543\u201351.","journal-title":"J Interv Cardiol"},{"issue":"1","key":"3317_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jjcc.2020.09.005","volume":"77","author":"T Akagi","year":"2021","unstructured":"Akagi T. Transcatheter closure of patent foramen ovale: current evidence and future perspectives. J Cardiol. 2021;77(1):3\u20139.","journal-title":"J Cardiol"},{"issue":"3","key":"3317_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jacc.2018.10.061","volume":"73","author":"J Wintzer-Wehekind","year":"2019","unstructured":"Wintzer-Wehekind J, et al. Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism. J Am Coll Cardiol. 2019;73(3):278\u201387.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3317_CR13","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022\u201332.","journal-title":"N Engl J Med"},{"issue":"6","key":"3317_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jacc.2020.11.068","volume":"77","author":"MK Mojadidi","year":"2021","unstructured":"Mojadidi MK, et al. Pooled analysis of pfo occluder device trials in patients with pfo and migraine. J Am Coll Cardiol. 2021;77(6):667\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3317_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/CRD.0000000000000205","volume":"27","author":"MK Mojadidi","year":"2019","unstructured":"Mojadidi MK, et al. Patent foramen ovale and hypoxemia. Cardiol Rev. 2019;27(1):34\u201340.","journal-title":"Cardiol Rev"},{"issue":"4","key":"3317_CR16","doi-asserted-by":"publisher","first-page":"100039","DOI":"10.1016\/j.jscai.2022.100039","volume":"1","author":"CJ Kavinsky","year":"2022","unstructured":"Kavinsky CJ, et al. SCAI guidelines for the management of patent foramen ovale. J Soc Cardiovasc Angiography Interventions. 2022;1(4):100039.","journal-title":"J Soc Cardiovasc Angiography Interventions"},{"issue":"1","key":"3317_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12974-019-1592-3","volume":"16","author":"C Rawat","year":"2019","unstructured":"Rawat C, et al. Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management. J Neuroinflammation. 2019;16(1):197.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"3317_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(18)30454-X","volume":"18","author":"GE Collaborators","year":"2019","unstructured":"Collaborators GE. Global, regional, and national burden of epilepsy, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18(4):357\u201375.","journal-title":"Lancet Neurol"},{"key":"3317_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-444-52898-8.00006-9","volume":"107","author":"A Neligan","year":"2012","unstructured":"Neligan A, Hauser WA, Sander JW. The epidemiology of the epilepsies. Handb Clin Neurol. 2012;107:113\u201333.","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"3317_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S1474-4422(11)70193-4","volume":"10","author":"P Ryvlin","year":"2011","unstructured":"Ryvlin P, Cucherat M, Rheims S. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol. 2011;10(11):961\u20138.","journal-title":"Lancet Neurol"},{"issue":"5","key":"3317_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GN Collaborators","year":"2019","unstructured":"Collaborators GN. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380.","journal-title":"Lancet Neurol"},{"issue":"3","key":"3317_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/head.12536","volume":"55","author":"BL Nye","year":"2015","unstructured":"Nye BL, Thadani VM. Migraine and epilepsy: review of the literature. Headache. 2015;55(3):359\u201380.","journal-title":"Headache"},{"issue":"Suppl 1","key":"3317_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10072-017-2902-0","volume":"38","author":"D Zarcone","year":"2017","unstructured":"Zarcone D, Corbetta S. Shared mechanisms of epilepsy, migraine and affective disorders. Neurol Sci. 2017;38(Suppl 1):73\u20136.","journal-title":"Neurol Sci"},{"issue":"2","key":"3317_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5694\/mja2.51141","volume":"215","author":"KK Cho","year":"2021","unstructured":"Cho KK, et al. Persistent pathology of the patent foramen ovale: a review of the literature. Med J Aust. 2021;215(2):89\u201393.","journal-title":"Med J Aust"},{"issue":"3","key":"3317_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","volume":"88","author":"KM Fiest","year":"2017","unstructured":"Fiest KM, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296\u2013303.","journal-title":"Neurology"},{"issue":"12","key":"3317_CR26","doi-asserted-by":"publisher","first-page":"926","DOI":"10.7326\/0003-4819-136-12-200206180-00015","volume":"136","author":"KM Kessler","year":"2002","unstructured":"Kessler KM. The CONSORT statement: explanation and elaboration. Consolidated Standards of reporting trials. Ann Intern Med. 2002;136(12):926\u20137. author reply 926-7.","journal-title":"Ann Intern Med"},{"issue":"6","key":"3317_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s12630-018-1109-z","volume":"65","author":"JTY Chow","year":"2018","unstructured":"Chow JTY, et al. Sample size calculations for randomized clinical trials published in anesthesiology journals: a comparison of 2010 versus 2016. Can J Anaesth. 2018;65(6):611\u20138.","journal-title":"Can J Anaesth"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03317-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T06:02:24Z","timestamp":1690437744000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03317-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3317"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03317-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Modifications to the trial procedures will be documented by protocol amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Protocol amendments"}},{"value":"Shown in <b>supplement file 2<\/b>.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Protocol"}},{"value":"for this study was received from the Ethics Committee of West China Hospital of Sichuan University (No. HXDZ21006), and recruitment started on December 1, 2022. All the participants are required to provide written informed consent. Our team confirmed that all methods were performed in accordance with the relevant guidelines and regulations. Study outcomes will be disseminated through peer-reviewed publications and academic conferences.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"282"}}